Market Overview

UPDATE: Credit Suisse Upgrades Dr. Reddy's Laboratories Limited to Outperform on Metropol Market Share

Share:

Credit Suisse raised its rating on Dr. Reddy's Laboratories Limited (NYSE: RDY) from Neutral to Outperform.

Credit Suisse said, "Our positive stance on Dr. Reddy's is driven by a strong pick-up in US sales in the coming quarters. Dr. Reddy's market share on Metoprolol has increased to 15% vs. expectation of 8-10%. Metoprolol market size is large at US$450 mn and is a high-margin product. Our interactions with Intas and Cadila suggested that Metoprolol approval for them is not a near-term event and therefore for at least the next six months Dr. Reddy's should continue to enjoy a high market share on Metoprolol."

Dr. Reddy's Laboratories Limited closed at $34.25 on Wednesday.

Latest Ratings for RDY

DateFirmActionFromTo
Sep 2019UpgradesUnderperformOutperform
Jun 2019Initiates Coverage OnEqual-Weight
May 2019DowngradesOverweightEqual-Weight

View More Analyst Ratings for RDY
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (RDY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TRVEvercore ISI GroupInitiates Coverage On
CAGRBC CapitalInitiates Coverage On30.0
AIGEvercore ISI GroupInitiates Coverage On
AVYCitigroupMaintains132.0
TIFMorgan StanleyMaintains94.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Credit Suisse Upgrades GlaxoSmithKline to Neutral; Pricing Policy Impact Priced In

UPDATE: Credit Suisse Upgrades Tesoro to Outperform on West Coast Crude Advantage